Doximity, Inc.

Doximity, Inc. (DOCS) Market Cap

Doximity, Inc. has a market capitalization of $4.64B.

Financials based on reported quarter end 2025-12-31

Price: $24.71

0.46 (1.90%)

Market Cap: 4.64B

NYSE · time unavailable

CEO: Jeffrey A. Tangney

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2021-06-24

Website: https://www.doximity.com

Doximity, Inc. (DOCS) - Company Information

Market Cap: 4.64B · Sector: Healthcare

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Analyst Sentiment

78%
Strong Buy

Based on 24 ratings

Analyst 1Y Forecast: $52.33

Average target (based on 2 sources)

Consensus Price Target

Low

$25

Median

$44

High

$63

Average

$43

Potential Upside: 75.5%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 DOXIMITY INC CLASS A (DOCS) — Investment Overview

🧩 Business Model Overview

Doximity Inc. (DOCS) operates as a professional network tailored for medical professionals, positioning itself as the “LinkedIn for doctors.” The company’s digital platform facilitates secure communication, collaboration, and information-sharing among physicians, nurse practitioners, physician assistants, and other healthcare stakeholders within the United States. Doximity’s network supports profiles, peer-to-peer messaging, curated medical newsfeeds, virtual telehealth visits, and multiple resources designed to streamline clinical workflows. By offering HIPAA-compliant communication tools, Doximity integrates seamlessly into the highly regulated healthcare environment, becoming an essential utility for its user base. DOCS’ business model is inherently asset-light, scalable, and deeply embedded with its end-users, resulting in strong network effects and recurring engagement.

💰 Revenue Streams & Monetisation Model

Doximity monetizes its physician network through a blend of subscription and advertising-based revenue streams: - Marketing Solutions: The largest component of revenue comes from digital marketing campaigns targeted toward physicians. Healthcare and pharmaceutical companies utilize Doximity’s platform for programmatic, direct marketing and educational content dissemination, benefiting from superior targeting enabled by Doximity’s verified clinical audience data. - Hiring Solutions: Healthcare recruitment professionals and institutions use premium subscription-based hiring solutions for targeted job postings, candidate search, and dedicated communication tools. Doximity’s reach and professional verification streamline high-value clinician recruitment. - Telehealth Solutions: Doximity Dialer and other telemedicine offerings extend the platform’s utility into virtual care, where premium features are packaged as add-on services for individual clinicians, groups, and enterprise healthcare providers. The platform’s freemium model fosters broad physician adoption, with advanced features and marketing access reserved for paying enterprise customers and partners. High gross margins are enabled by the digital delivery of services and the platform-based approach.

🧠 Competitive Advantages & Market Positioning

Doximity has established a moat around its business through several durable advantages: - Network Effects: With a critical mass of verified medical professionals, network value increases as more clinicians join, creating a virtuous cycle that is difficult for competitors to replicate. - First-mover Status: By focusing exclusively on healthcare professionals since inception, Doximity has become the default professional utility for the sector, mitigating fragmentation. - Data and User Trust: Rigorous physician verification, medical licensure tracking, and HIPAA-grade security engender trust from both users and industry stakeholders, a key differentiator versus horizontal social networks. - Integrated Clinical Workflow: Embedded functionality such as secure messaging, telehealth, faxing, and CME-accredited content creates sticky daily use, further raising switching costs. - Brand Strength: High recognition among U.S. physicians has cemented Doximity as the physician-centric professional network. Within the U.S. market, Doximity faces limited direct competition at scale. Broader digital players (e.g., LinkedIn) lack medical focus and regulatory tailoring, while telehealth-specific incumbents do not offer comprehensive professional networking or data-driven marketing solutions.

🚀 Multi-Year Growth Drivers

Doximity’s long-term growth is supported by multiple secular and company-specific tailwinds: - Shift to Digital Healthcare Marketing: The pharmaceutical and medical device industries are steadily reallocating marketing budgets from traditional, in-person channels toward digital avenues. Doximity is a leading beneficiary, given its audience precision and compliance with industry regulations. - Healthcare Workforce Demand: Persistent shortages and mobility of healthcare staff drive increased spending on recruitment and hiring solutions. - Expansion of Telehealth: The normalization of virtual care workflows accelerates adoption of Doximity’s telemedicine offerings, cementing its relevance beyond networking. - New Product Innovation: Continued integration of clinical tools, AI-driven features, and workflow automation deepens user engagement and enables ARPU (average revenue per user) expansion. - Adjacency Expansion: Opportunity exists to extend into nursing, pharmacy, and international healthcare verticals, as well as enlarging service scope for life sciences and hospital systems. These factors combine to provide a durable runway for top-line and margin expansion.

⚠ Risk Factors to Monitor

Investors should be aware of several key risks: - Healthcare Regulatory Environment: Frequent changes to HIPAA, data privacy, telehealth reimbursement, and pharmaceutical marketing regulations could increase compliance costs or constrain platform offerings. - User Engagement Risk: A decline in active medical professional users, due to competing platforms or shifting clinician preferences, would erode Doximity’s network effects and core value proposition. - Customer Concentration: Doximity’s largest clients — major pharmaceutical companies — represent significant revenue, increasing exposure to industry-specific marketing budget cycles and contract renewals. - Competitive Entry: New or existing digital health platforms, large physician staffing agencies, or generalist platforms entering healthcare could increase competitive pressure. - Market Saturation: As penetration among U.S. physicians matures, growth rates could slow without successful adjacencies or deepening engagement.

📊 Valuation & Market View

Doximity is generally valued with reference to high-growth SaaS and professional network peers, reflecting its scalable, subscription-oriented, and high-margin business model. Key valuation metrics include EV/revenue, EV/EBITDA, and free cash flow multiples, often carrying a premium due to strong network effects, durable gross margins, and secular growth tailwinds. The company’s asset-light model, high free cash flow conversion, and secular positioning in healthcare tech are frequently cited by market participants as justification for its valuation positioning. The market’s long-term view generally incorporates recursive benefits from operating leverage, sustained top-line expansion, and proven track record of profitability. Future valuation upside or downside is likely to be hinged upon continued expansion of marketing and telehealth solutions, execution in adjacent monetization verticals, and effective management of regulatory and end-market risks. Comparisons with broader healthcare IT players and network-centric SaaS firms are frequently referenced in peer benchmarking.

🔍 Investment Takeaway

Doximity stands out as a mission-critical digital platform underpinning physician communication, workflow, and career management within the U.S. healthcare ecosystem. Its unique blend of professional network, recruiting solutions, and telehealth tools creates substantial switching costs and strong user engagement, benefited by powerful network effects and category leadership. The company is positioned for durable multi-year growth, underpinned by the digital transformation of healthcare marketing, the rise of telemedicine, and the perennial demand for physician and clinician hiring. While regulatory and competitive risks warrant ongoing monitoring, Doximity’s entrenched position, asset-light business model, and high margins offer a compelling investment case among health tech equities. For investors seeking exposure to the digitalization of healthcare, physician-centric professional networks, and high-margin SaaS platforms, Doximity presents a differentiated and defensible opportunity, albeit one whose premium valuation assumes ongoing successful execution on product innovation, network engagement, and adjacent market growth.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"For the quarter ended December 31, 2025, DOCS reported revenue of $185.1 million and a net income of $61.6 million, indicating a net margin of approximately 33.3%. Earnings per share (EPS) stood at $0.33. Free cash flow for the period was strong at $62.9 million, suggesting robust cash generation capabilities. Year-over-year growth is not provided, but given the stable income and cash flow figures, DOCS appears to maintain financial stability. The balance sheet exhibits a healthy position with total assets of $1.16 billion against total liabilities of $177.7 million, yielding substantial equity and net cash of $54.1 million, underscoring financial resilience. DOCS did not declare any dividends but engaged in substantial stock buybacks amounting to $158.6 million, supporting shareholder value. Analyst consensus on the stock places the average price target at $49.6, with a high estimate of $81, signaling positive market sentiment. Overall, DOCS's valuation will be influenced by its ability to sustain revenue growth and profitability amidst market fluctuations."

Revenue Growth

Positive

Revenue stability is evident with steady figures. Detailed growth rates are not provided, but the revenue drivers appear solid.

Profitability

Strong

Net margin at 33.3% and positive EPS indicate strong profitability, enhanced by efficient operations.

Cash Flow Quality

Good

Free cash flow is robust. No dividends declared, but significant buybacks boost shareholder value.

Leverage & Balance Sheet

Strong

Strong asset base, low liabilities, and net cash position demonstrate excellent financial health.

Shareholder Returns

Good

Substantial stock repurchases enhance shareholder value. Potential for improved returns if growth continues.

Analyst Sentiment & Valuation

Positive

Analyst targets show optimism, though there is a wide range highlighting mixed valuation views.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Doximity's Q3 2026 performance showed solid revenue growth and strong engagement metrics, despite facing challenges related to policy uncertainty impacting future budgets. The company demonstrated its commitment to AI innovation while maintaining a cautious outlook, believing that longer-term growth will benefit from robust customer uptake and revenue opportunities in underserved markets.

Growth

  • Revenue increased to $185 million, a 10% year-on-year growth.
  • Net revenue retention rate of 112% for trailing twelve months.
  • 126 customers contributing at least $500,000 each in subscription-based revenue.

Business Development

  • Surpassed 3 million registered members on the platform.
  • Over 100 health systems have purchased access to AI tools, covering 180,000 prescribers.

Financials

  • Adjusted EBITDA margin was 60% or $111 million, exceeding guidance.
  • Free cash flow generated in Q3 was $58.5 million.
  • Cash and equivalents at quarter-end totaled $735 million.

Capital & Funding

  • Repurchased $196.8 million worth of shares during Q3.
  • Board approved a new $500 million open-ended repurchase authorization.

Operations & Strategy

  • Building trusted AI tools with a focus on peer-reviewed clinical answers.
  • Intending to launch commercialized AI products later this year.
  • Continued investment in AI infrastructure and related training programs.

Market & Outlook

  • Expecting revenue range of $143 million to $144 million for Q4 2026.
  • Full fiscal year revenue guidance from $642.5 million to $643.5 million, representing 13% growth.

Risks Or Headwinds

  • Short-term industry-wide policy headwinds impacting Q4 expectations.
  • Customer uncertainty regarding recent policy changes and budget planning.

Sentiment: MIXED

Note: This summary was synthesized by AI from the DOCS Q3 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (DOCS)

© 2026 Stock Market Info — Doximity, Inc. (DOCS) Financial Profile